Medicare Enrolled

Dr. Larry Payne, M.D.

Ophthalmology · Gainesville, GA
Low-engagement
1485 JESSE JEWELL PARKWAY NE, Gainesville, GA 30501
7705341711
In practice since 2006 (19 years)
NPI: 1366504474 verify on NPPES ↗
High
DATA COVERAGE
Data in 3 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Payne from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Payne? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Payne

Dr. Larry Payne is an ophthalmology specialist in Gainesville, GA, with 19 years of NPI registration.

Between the years covered by Open Payments, Dr. Payne received a total of $3,626 from 23 pharmaceutical and/or device companies across 136 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in ophthalmology. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Payne is High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 19 years in practice $3,626 industry payments

Industry Payment Transparency

Open Payments through 2022 ↗
$3,626
Total received (2018-2022)
Avg $725/year across 5 years
Top 32% in GA for ophthalmology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
23
Companies
136
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$3,626 (100.0%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2022
$142
2021
$791
2020
$600
2019
$738
2018
$1,354

Payments by company (2022)

Consulting
Speaking
Meals & Travel
Research
Sun Pharmaceutical Industries Inc.
$86
Horizon Therapeutics plc
$37
Bausch & Lomb Americas Inc.
$19
Top 3 companies account for 100.0% of 2022 payments
All-time payments by company (2018-2022) ›
Johnson & Johnson Surgical Vision, Inc.
$1,261
Allergan, Inc.
$425
Glaukos Corporation
$234
Alcon Laboratories Inc
$229
Sun Pharmaceutical Industries Inc.
$193
SUN PHARMACEUTICAL INDUSTRIES INC.
$184
Alcon Vision LLC
$169
Mallinckrodt Hospital Products Inc.
$144
Allergan Inc.
$139
Novartis Pharmaceuticals Corporation
$117
Shire North American Group Inc
$113
Aerie Pharmaceuticals, Inc.
$106
Akorn, Inc.
$85
Carl Zeiss Meditec, Inc.
$43
Horizon Therapeutics plc
$37
Bausch & Lomb, a division of Bausch Health US, LLC
$36
Carl Zeiss Meditec AG
$19
Eyevance Pharmaceuticals LLC
$19
Bausch & Lomb Americas Inc.
$19
Ocular Therapeutix, Inc.
$16
Omeros Corporation
$13
TissueTech, Inc.
$13
Alimera Sciences, Inc.
$11
Top 3 companies account for 53.0% of all-time payments
Associated products mentioned in payments ›
ACTHAR · ALPHAGAN P · AcrySof IQ PanOptix · AcrySof IQ VIVITY IOL · AzaSite · BOTOX COSMETIC · BROMSITE · BromSite (bromfenac ophthalmic solution) 0.075% · CEQUA · COMBIGAN · Catalys Laser System · Cequa · CyPass · DURYSTA · Flarex · ILUVIEN · LUMIGAN · LenSx · Luxor · None Specified · OPMI Lumera · ORA · Omidria · Photrexa · Prokera · RESTASIS · RESTASIS MULTIDOSE · ReSTOR · ReSure Sealant · Rhopressa · Rocklatan · TEPEZZA · TRAVATAN Z · Tecnis 1-piece IOL · Tecnis Multifocal Family of 1-piece IOLS · VYZULTA · XIIDRA · enVista MX60 IOL · iStent Trabecular Micro-Bypass Stent System · iStent inject Trabecular Micro-Bypass Stent System · iStent inject W · rocklatan
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

Most payments (100%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.

Looking for an ophthalmology specialist in Gainesville?
Compare ophthalmologists in the Gainesville area by procedure volume, costs, and industry payment transparency.
Browse ophthalmologists nearby

Geographic Context

Ophthalmologists within 10 mi
27
Per 100K population
13.0
County median income
$77,430
Nearest hospital
NORTHEAST GEORGIA MEDICAL CENTER, INC
0.0 mi

Data Sources

Provider Registry NPPES Weekly updates
Medicare Enrollment PECOS Monthly updates
Practice Data — No data N/A
Industry Payments Open Payments CY 2022
Disciplinary History — Not public N/A

This provider has data in 3 of 4 available federal datasets, with a Data Coverage level of High. This reflects how much public data is available about a provider. How we calculate this →

Summary

Dr. Payne is an ophthalmology specialist, with low-engagement industry engagement, with 19 years of NPI registration.

This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →

Frequently Asked Questions

Does Dr. Payne receive payments from pharmaceutical companies?
Yes. Dr. Payne received a total of $3,626 from 23 companies across 136 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
What does Data Coverage mean?
Data Coverage (currently High for Dr. Payne) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →